Antiproliferative effects of isoalantolactone in human liver cancer cells are mediated through caspase-dependent apoptosis, ROS generation, suppression of cell migration and invasion and targeting Ras/Raf/MEK signalling pathway

  • Zhi-cong Wu Department of Pharmaceutics, Shijiazhuang People’s Hospital, Shijiazhuang, Hebei 050000, China
  • Xin-geng Hui Department of Pharmaceutics, Shijiazhuang People’s Hospital, Shijiazhuang, Hebei 050000, China
  • Lin Huo Department of Pharmaceutics, Hebei Chest Hospital, Shijiazhuang, Hebei 050000, China
  • Dong-xiao Sun Department of Pharmaceutics, Shijiazhuang People’s Hospital, Shijiazhuang, Hebei 050000, China
  • Wen Peng Department of Pharmaceutics, Shijiazhuang People’s Hospital, Shijiazhuang, Hebei 050000, China
  • Ying Zhang Department of Pharmaceutics, Shijiazhuang People’s Hospital, Shijiazhuang, Hebei 050000, China
  • Xiao-bing Li Department of Pharmaceutics, Shijiazhuang People’s Hospital, Shijiazhuang, Hebei 050000, China
  • Tian Ma Department of Pharmaceutics, Shijiazhuang People’s Hospital, Shijiazhuang, Hebei 050000, China
  • Wen-hui Li Department of Pharmaceutics, Shijiazhuang People’s Hospital, Shijiazhuang, Hebei 050000, China
  • Jing Liang Department of Pharmaceutics, Hebei Chest Hospital, Shijiazhuang, Hebei 050000, China
  • Zhi-qiang Sun Department of Pharmaceutics, Shijiazhuang People’s Hospital, Shijiazhuang, Hebei 050000, China
DOI: https://doi.org/10.18388/abp.2020_5704

Abstract

The main objective of this study was to evaluate the in vitro antiproliferative effects of isoalantolactone against liver cancer cells (Hep-G2) and also monitor its mechanism of action. The MTT assay was involved in proliferation assessments and phase contrast microscopy was used to check cellular morphology. Acridine orange/ethidium bromide staining along with western blotting was used to evaluate proapoptotic effects of isoalantolactone. DCFH-DA staining was used in ROS measurements. Transwell migration and invasion assay were executed to check the effects of isoalantolactone on migration and invasion of Hep-G2 cells. Western blotting was used to check the expressions of Ras/Raf/MEK signalling pathway in Hep-G2 cells. Results demonstrated that isoalantolactone significantly (*p<0.05 and **p<0.01) inhibited the proliferation of Hep-G2 cells in a concentration and time-reliant fashion. The IC50 value of the tested isoalantolactone molecule was found to be 71.2 µM and 53.4 µM at 12 h and 24 h time intervals respectively. Moreover, the antiproliferative effects of isoalantolactone were mediated through induction of caspase-dependent apoptosis and oxidative stress (ROS mediated). The proapoptotic effects of isoalantolactone were evident from morphological assessments and improved expressions of caspase-3, -8, and -9 and Bax while antiapoptotic Bcl-2 was reduced significantly. Additionally, antiproliferative and proapoptotic effects of isoalantolactone were found to be a consequence of blocking of Ras/Raf/MEK signalling in Hep-G2 cells. Furthermore, isoalantolactone significantly (*p<0.05) targeted the migration and invasion of Hep-G2 cells. In conclusion, these results validated that isoalantolactone shows strong antiproliferative activity against Hep-G2 liver cancer cells. Therefore, it could prove as a leading candidate in liver cancer research, drug discovery and design.

Published
2022-04-07
Issue
Vol. 69 No. 2 (2022)
Section
Articles

Copyright (c) 2022 Zhi-cong Wu, Xin-geng Hui , Lin Huo, Dong-xiao Sun, Wen Peng , Ying Zhang, Xiao-bing Li, Tian Ma, Wen-hui Li, Jing Liang, Zhi-qiang Sun

Creative Commons License

This work is licensed under a Creative Commons Attribution-ShareAlike 4.0 International License.

Acta Biochimica Polonica is an open access quarterly and publishes four issues a year. All contents are distributed under the Creative Commons Attribution-ShareAlike 4.0 International (CC BY-SA 4.0) license. Everybody may use the content following terms: Attribution — You must give appropriate credit, provide a link to the license, and indicate if changes were made, ShareAlike — If you remix, transform, or build upon the material, you must distribute your contributions under the same license as the original. There are no additional restrictions — You may not apply legal terms or technological measures that legally restrict others from doing anything the license permits.

Copyright for all published papers © stays with the authors.

Copyright for the journal: © Polish Biochemical Society.